About Axiomed
Axiomed is a company based in Garfield (United States) founded in 2001 was acquired by KIC Ventures in December 2014.. Axiomed has raised $76.77 million across 15 funding rounds from investors including Investor, Early Stage Partners and MB Venture Partners. Axiomed offers products and services including Freedom Cervical Disc, Freedom Lumbar Disc, and Freedom Lateral Lumbar Disc. Axiomed operates in a competitive market with competitors including M6-Global, Discure Technologies, 33 Medical and M6 disc replacement, among others.
- Headquarter Garfield, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Axiomed Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$76.77 M (USD)
in 15 rounds
-
Latest Funding Round
$100 K (USD), Series D
Nov 21, 2017
-
Investors
Investor
& 9 more
-
Employee Count
Employee Count
-
Acquired by
KIC Ventures
(Dec 03, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Axiomed
Axiomed offers a comprehensive portfolio of products and services, including Freedom Cervical Disc, Freedom Lumbar Disc, and Freedom Lateral Lumbar Disc. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for replacing cervical discs to restore normal spine function.
Lumbar disc replacement for pain relief and motion restoration.
Lateral disc for improved spine performance in degenerative cases.
Funding Insights of Axiomed
Axiomed has successfully raised a total of $76.77M across 15 strategic funding rounds. The most recent funding activity was a Series D round of $100 thousand completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Series D — $100,000
-
First Round
First Round
(10 Feb 2003)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Series D - Axiomed | Valuation |
investors |
|
| Oct, 2017 | Amount | Series D - Axiomed | Valuation |
investors |
|
| Jan, 2017 | Amount | Series D - Axiomed | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Axiomed
Axiomed has secured backing from 10 investors, including venture fund investors. Prominent investors backing the company include Investor, Early Stage Partners and MB Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by the Wallenberg family into Nordic sectors.
|
Founded Year | Domain | Location | |
|
Capital and strategic direction are provided to life science companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Axiomed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Axiomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axiomed Comparisons
Competitors of Axiomed
Axiomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as M6-Global, Discure Technologies, 33 Medical and M6 disc replacement, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for musculoskeletal disorders are developed and offered.
|
|
| domain | founded_year | HQ Location |
Bioelectronic solutions for spinal and joint conditions are developed.
|
|
| domain | founded_year | HQ Location |
Pioneers spinal devices for minimally invasive treatments and pain relief.
|
|
| domain | founded_year | HQ Location |
Provides artificial discs mimicking natural structure for cervical and lumbar spine surgery.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Axiomed
Frequently Asked Questions about Axiomed
When was Axiomed founded?
Axiomed was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is Axiomed located?
Axiomed is headquartered in Garfield, United States. It is registered at Garfield, New Jersey, United States.
Is Axiomed a funded company?
Axiomed is a funded company, having raised a total of $76.77M across 15 funding rounds to date. The company's 1st funding round was a Series D of $1.03M, raised on Feb 10, 2003.
What does Axiomed do?
Axiomed was founded in 2001 in Garfield, United States, as a spinal orthopedics company. Products focused on restoring spinal function in patients with degenerative spine disease are developed, featuring a one-piece design with a viscoelastic polymeric core. The Freedom Lumbar and Cervical Discs, serving as lumbar and cervical replacement devices, have obtained CE Mark approval for European Union distribution. US regulatory approval for this technology is being pursued.
Who are the top competitors of Axiomed?
Axiomed's top competitors include Discure Technologies, M6-Global and 33 Medical.
What products or services does Axiomed offer?
Axiomed offers Freedom Cervical Disc, Freedom Lumbar Disc, and Freedom Lateral Lumbar Disc.
Who are Axiomed's investors?
Axiomed has 10 investors. Key investors include Investor, Early Stage Partners, MB Venture Partners, Reservoir Venture Partners, and Thomas, McNerney & Partners.